open access
Vol 55, No 1 (2021)
Letter to the Editors
Submitted: 2020-07-30
Accepted: 2020-08-03
Published online: 2020-10-07
Get Citation
A comment on the paper ‘Biomarkers in Multiple Sclerosis’ by Sapko et al.
12, 3, 2
Affiliations- Lab for Clinical Neurochemistry and Neurochemical Dementia Diagnostics, Universitätsklinikum Erlangen, Department of Psychiatry and Psychotherapy, Germany
- Department of Neurodegeneration Diagnostics, Medical University of Białystok, Białystok, Poland;
- Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and FriedrichAlexander Universität Erlangen-Nürnberg, Erlangen, Germany;
open access
Vol 55, No 1 (2021)
Letters to the Editors
Submitted: 2020-07-30
Accepted: 2020-08-03
Published online: 2020-10-07
Abstract
Not available
Abstract
Not available
Get Citation
About this articleTitle
A comment on the paper ‘Biomarkers in Multiple Sclerosis’ by Sapko et al.
Journal
Neurologia i Neurochirurgia Polska
Issue
Article type
Letter to the Editors
Pages
115-116
Published online
2020-10-07
Page views
659
Article views/downloads
615
DOI
Pubmed
Bibliographic record
Neurol Neurochir Pol 2021;55(1):115-116.
Authors
Piotr Lewczuk
Johannes Kornhuber
Barbara Mroczko
References (7)- Andersson M, Alvarez-Cermeño J, Bernardi G, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry. 1994; 57(8): 897–902.
- Kulakowska A, Mroczko B, Mantur M, et al. Multiplexing analysis of the polyspecific intrathecal immune response in multiple sclerosis. 2012: Methods.
- Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem. 1991; 37(7): 1153–1160.
- Reiber H. Flow rate of cerebrospinal fluid (CSF) — A concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. Journal of the Neurological Sciences. 1994; 122(2): 189–203.
- Reiber H, Peter J. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. Journal of the Neurological Sciences. 2001; 184(2): 101–122.
- Sapko K, Jamroz-Wiśniewska A, Marciniec M, et al. Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors. Neurol Neurochir Pol. 2020; 54(3): 252–258.
- Tumani H, Petereit HF, Gerritzen A, et al. S1 guidelines “lumbar puncture and cerebrospinal fluid analysis” (abridged and translated version). Neurological Research and Practice. 2020; 2(1).
